An increased activity of AR coupled with the upregulation of a subset of AR-related co-activators mainly AP-1, NF-κB, and cAMP response element-binding protein (CBP) and co-activator protein p300 have contributed to the aggressiveness of the PCa disease and the progression to AIPC. The gene discussed is JUNB; the disease is posterior cortical atrophy.